Biblio
Export 794 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is V [Clear All Filters]
“The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 60, no. 2, pp. 561-576, 2017.
, “The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 60, no. 2, pp. 561-576, 2017.
, “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
, “Challenges and Considerations Related to Studying Dementia in Blacks/African Americans.”, J Alzheimers Dis, vol. 60, no. 1, pp. 1-10, 2017.
, “Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1005-1017, 2017.
, “Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.”, J Alzheimers Dis, 2017.
, “Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1393-1413, 2017.
, “Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.”, J Alzheimers Dis, vol. 57, no. 2, pp. 447-459, 2017.
, “Cognitive Efficiency in Alzheimer's Disease is Associated with Increased Occipital Connectivity.”, J Alzheimers Dis, vol. 57, no. 2, pp. 541-556, 2017.
, “Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 87-97, 2017.
, “A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1037-1054, 2017.
, “Cortical Cerebral Microinfarcts on 3 Tesla MRI in Patients with Vascular Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1443-1450, 2017.
, “Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1533-1545, 2017.
, “Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1533-1545, 2017.
, “Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1533-1545, 2017.
, “Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1533-1545, 2017.
, “Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 707-719, 2017.
, “Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
, “Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
, “Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1261-1272, 2017.
, “Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.”, J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
, “Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 659-667, 2017.
, “Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting.”, J Alzheimers Dis, vol. 59, no. 3, pp. 961-974, 2017.
, “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
, “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
,